Emerging markets weekly technical analysis — week 9 of a buy setup, +2.5% performance since entry. Double bottom in the 35 area held; structure now approaching a heavily contested resistance above the 37 zone.

Week 10 of a buy signal with +10% performance since entry. All 3 statistical model targets already hit, stop at breakeven: zero risk. The residual capital can keep running until the next inversion signal.

Starbucks sell signal at week 2: the confirmation week closed bullish — a warning for anyone holding a short position. Our technical analysis flags trading as not recommended, with the stock still 8.8% above its 200-week moving average.

Sanofi week 6 of a sell signal. Technical analysis shows a double bottom at 72 with a 9% rebound complicating the trade setup — sell pressure holds directionally, but a structured floor is forming. Trading not recommended.

Safran SA weekly trade setup, week 3 of a buy signal with +7.7% performance since entry. Confirmation week closed bearish and signal strength is fading: dynamic stop tighter than the structural level, protecting the open position.

Week 4 of the sell signal on Recursion Pharmaceuticals — the week closed up 2.5% after 2 consecutive declines. The rebound failed to break the wall of moving averages in the 3.3 area: technical analysis still points bearish and trading is not recommended per our model.